Astria Therapeutics Inc. (ATXS)
6.04
-0.06 (-0.98%)
At close: Mar 04, 2025, 11:19 AM
Astria Therapeutics Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 175.53M | 20.52M | 86.51M | 24.93M | 9.9M | 15.29M | 16.37M | 23.6M | 62.78M | 14.67M | 30.47M | 5.43K |
| Short-Term Investments | 71M | 205.91M | 39M | 20M | 26.34M | 22.28M | n/a | 14.93M | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | 113K | 113K | 113K | 113K | n/a | n/a | n/a |
| Other Long-Term Assets | 3.36M | 3.25M | 45K | 165K | 473K | 85K | n/a | n/a | 22K | 654K | 113K | -585 |
| Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 4.41M | 1.25M | 1.45M | 2.79M | 5.43M | 2.69M | 2.19M | 2M | 772K | 354K | 107K | 182.00 |
| Total Current Assets | 250.94M | 226.44M | 127.08M | 46.33M | 38.96M | 38.91M | 17.46M | 39.53M | 63.58M | 15.02M | 30.58M | 5.62K |
| Property-Plant & Equipment | 363K | 948K | 394K | 966K | 2.35M | 56K | 321K | 568K | 504K | 288K | 308K | 585.00 |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 3.72M | 4.2M | 439K | 1.13M | 2.82M | 254K | 434K | 681K | 639K | 942K | 421K | 585.00 |
| Total Assets | 254.67M | 230.63M | 127.51M | 47.46M | 41.78M | 39.17M | 17.9M | 40.21M | 64.22M | 15.96M | 31M | 6.31K |
| Account Payables | 1.51M | 788K | 1.56M | 1.54M | 1.2M | 1.41M | 773K | 1.41M | 1.33M | 1.13M | 651K | 780.00 |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 2.43M | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | 329K | 1.16M | 730K | 1.3M | 2.45M | n/a | 2.48M | 3.24M | 3.17M | 309K | n/a | n/a |
| Other Current Liabilities | 9.71M | 7.11M | 2.92M | 3.55M | 1.34M | 2.76M | 2.76M | 3.68M | 3.28M | 2.79M | 2.28M | 1.11K |
| Total Current Liabilities | 11.55M | 582K | 5.2M | 6.39M | 5.03M | 4.17M | 6.02M | 8.32M | 7.81M | 4.23M | 2.93M | 1.89K |
| Long-Term Debt | n/a | 357K | n/a | 397K | 1.03M | n/a | n/a | 2.48M | 5.72M | 4.44M | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | 56K | 89K | 319K | 177K | 80.34M | 80.26M | n/a |
| Total Long-Term Liabilities | n/a | 8.84M | n/a | 397K | 1.03M | 56K | 89K | 2.8M | 5.92M | 84.78M | 80.26M | n/a |
| Total Liabilities | 11.55M | 9.42M | 5.2M | 6.79M | 6.06M | 4.23M | 6.11M | 11.12M | 13.73M | 89.02M | 83.19M | 2.03K |
| Total Debt | 329K | 939K | 365K | 1.05M | 2.25M | n/a | 2.48M | 5.72M | 8.95M | 4.75M | n/a | n/a |
| Common Stock | 41K | 28K | 13K | 20K | 12K | 7K | 24K | 19K | 15K | 1K | n/a | 5.00 |
| Retained Earnings | -580.53M | -507.64M | -455.81M | -260.9M | -223.6M | -197.3M | -171.43M | -144.07M | -108.01M | -75.38M | -53.5M | -35.38K |
| Comprehensive Income | n/a | -79K | n/a | n/a | n/a | -4K | n/a | -4K | -64.22M | -80.25M | 0.00 | n/a |
| Shareholders Equity | 243.12M | 221.22M | 122.31M | 40.67M | 35.72M | 34.94M | 11.79M | 29.09M | 50.49M | -73.05M | -52.18M | 4.29K |
| Total Investments | 71M | 205.91M | 39M | 20M | 26.34M | 22.28M | 113K | 14.93M | 113K | n/a | n/a | n/a |